JOHN AVERETTE: Open Payments
NPI 1689139768 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 24 payments from 7 companies in 2025. Trend: 2023 $28,025 · 2024 $4,686 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $153 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| Alkermes, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Indivior Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: FANAPT, UZEDY, ARISTADA, COBENFY, SUBLOCADE, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across NC — which companies pay providers there.
